Emery, S <br/><br/>
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects.  [electronic resource] 

 -  Human vaccines   
 - 232-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1554-8600 
<br/><br/><label>Standard No.: </label>10.4161/hv.1.6.2342  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--adverse effects<br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Fowlpox virus--genetics<br/>Gene Products, gag--genetics<br/>Gene Products, pol--genetics<br/>Genetic Vectors<br/>HIV Antibodies<br/>HIV Infections--drug therapy<br/>HIV-1--genetics<br/>Humans<br/>Interferon-gamma--administration & dosage<br/>Lymphocyte Subsets<br/>Male<br/>Middle Aged<br/>Vaccines, Synthetic--adverse effects<br/>Viral Load